Fundacio Puigvert

Barcelona 55 trials 27 recruiting

55 Registered trials

27 Currently recruiting

Organisation

Fundacio Puigvert

Location

Barcelona, Spain

Identifier

ORG-100032773

Address

Cartagena 340-350, 8025, Spain

Departments

#3275:Urologia
Department of Nephrology
Department of Urology
Medical Oncology
Nefrología
Nefrología y Trasplante Renal
Nephrologist
Nephrology
Nephrology Department
Nephrology Service
None
Obstetricia y Ginecología
Oncologia
Oncology-Urology Unit
Servicio de Nefrología
Servicio de Urologia
Trasplante Renal
Urologia
Urology

Clinical trials at this site (55)

Search interface

A Phase 2a Study to Evaluate Setanaxib in Patients with Alport Syndrome Ended

2023-505292-73-00 Alport syndrome 4 2024-01-10
A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE) Ended

2022-502227-22-00 Autoimmune disease 4 2023-10-25
A study to test BI 764198 in people with a type of kidney disease called focal segmental glomerulosclerosis Ended

2024-511706-23-00 Focal segmental glomerulosclerosis 4 2022-05-31
Phase 2 Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) Ended

2023-504825-38-00 Lupus Nephritis (LN) Immunoglobulin A Nephropathy (IgAN 4 2022-04-15
A Phase 2, Open-Label, Multi-Center, Randomized Study of TAR-200 in Combination with Cetrelimab and Cetrelimab Alone in Participants with Mu… Ended

2023-507189-17-00 Muscle-Invasive Urothelial Carcinoma of the Bladder 4 2022-01-09
A study of enfortumab vedotin given in the bladder for treatment of patients with non-muscle invasive bladder cancer (NMIBC). Ended

2023-503388-40-00 Non-muscle invasive bladder cancer 3 2021-08-24
A trial to learn how well darolutamide plus androgen deprivation therapy (ADT) works in comparison to placebo plus ADT in men with prostate … Ended

2022-502244-12-00 Metastatic hormone-sensitive prostate cancer (mHSPC) 5 2021-02-22